Crescita Therapeutics Inc.
CTX.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 358.40K | -947.90K | -2.20M | -2.02M | -2.01M |
| Total Depreciation and Amortization | 1.04M | 990.60K | 957.70K | 997.30K | 1.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -571.50K | 8.70K | 144.50K | 143.10K | 236.30K |
| Change in Net Operating Assets | 647.60K | 882.80K | 2.44M | 2.85M | 1.56M |
| Cash from Operations | 1.48M | 934.30K | 1.34M | 1.97M | 799.20K |
| Capital Expenditure | -1.02M | -1.03M | -1.57M | -1.53M | -1.35M |
| Sale of Property, Plant, and Equipment | 0.00 | 57.20K | 57.20K | 57.20K | 57.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.02M | -973.90K | -1.52M | -1.47M | -1.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -463.00K | -455.00K | -449.00K | -441.00K | -433.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -300.00K | -296.00K | -285.00K | -320.00K | -396.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | -50.00K | -50.00K | -100.00K | -50.00K |
| Cash from Financing | -582.20K | -575.10K | -564.10K | -628.30K | -646.50K |
| Foreign Exchange rate Adjustments | 42.90K | 22.40K | 29.60K | 30.50K | -15.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -81.50K | -592.30K | -715.70K | -95.30K | -1.16M |